Related Experiment Video

Updated: Aug 4, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease

Joelle M van der Walt1, Kristin K Nicodemus, Eden R Martin

  • 1Department of Medicine, and Center for Human Genetics, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA.

American Journal of Human Genetics
|March 6, 2003
PubMed

Insights

Mitochondrial DNA variations in haplogroups J and K, specifically SNP 10398G, show a protective effect against Parkinson disease (PD) in white individuals. This protective association is more pronounced in women, suggesting a role for mitochondrial complex I in PD pathogenesis.

Area of Science:

  • Neurogenetics
  • Mitochondrial Biology
  • Epidemiology

Background:

  • Mitochondrial dysfunction, particularly in Complex I, is linked to Parkinson disease (PD) pathogenesis.
  • Mitochondrial DNA (mtDNA) encodes key components of the electron transport chain, including Complex I.

Purpose of the Study:

  • To investigate the association between European mtDNA haplogroups and PD risk in a white population.
  • To identify specific mtDNA single-nucleotide polymorphisms (SNPs) contributing to PD susceptibility.

Main Methods:

  • Genotyping of 10 SNPs defining European mtDNA haplogroups in 609 PD patients and 340 controls.
  • Statistical analysis including odds ratios (OR) and confidence intervals (CI) to assess risk association.
  • Stratification by sex to evaluate sex-specific effects.

Main Results:

  • Haplogroups J and K were associated with a significantly decreased risk of PD (OR 0.55 and 0.52, respectively).
  • SNP 10398G, defining haplogroups J and K, showed a strong protective effect (OR 0.53), causing a T-to-A amino acid change in ND3.
  • The protective effect of SNP 10398G was stronger in women (OR 0.43). SNP 9055A in ATP6 also showed protection in women (OR 0.45).

Conclusions:

  • mtDNA variation, particularly within Complex I (ND3), plays a significant role in PD susceptibility among white individuals.
  • The findings highlight the importance of mitochondrial genetic factors in PD etiology and may explain the involvement of Complex I in the disease.

More Related Videos

Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice07:41

Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice

Published on: June 8, 2022

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model06:07

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...